INTRODUCTION AND OBJECTIVES: Little glucose metabolism is generally thought to occur in prostate cancer, leading to low diagnostic accuracy of 18F-fluoro-2-deoxyglucose (FDG) positron emission tomography-computed tomography (PET/CT). Nevertheless, this modality is reportedly useful for identifying high-risk local cancers. We therefore investigated whether local FDG uptake by the prostate reflects the perioperative results of robot-assisted laparoscopic radical prostatectomy (RALP).
INTRODUCTION AND OBJECTIVES: Little glucose metabolism is generally thought to occur in prostate cancer, leading to low diagnostic accuracy of 18F-fluoro-2-deoxyglucose (FDG) positron emission tomography-computed tomography (PET/CT). Nevertheless, this modality is reportedly useful for identifying high-risk local cancers. We therefore investigated whether local FDG uptake by the prostate reflects the perioperative results of robot-assisted laparoscopic radical prostatectomy (RALP).
METHODS: Between November 2012 and August 2016, a total of 248 patients underwent RALP at our institution. Of these, subjects in this study comprised 116 patients in whom FDG-PET/CT was employed for preoperative staging. We retrospectively compared perioperative results between patients, stratified for local FDG uptake in the prostate. Patients who had received preoperative hormone therapy were excluded from the study. FDG uptake was rated based on clinical reports prepared by two radiation diagnosticians. Patient background characteristics, perioperative results and postoperative pathological results were compared between subjects divided into PET-positive and -negative groups.
RESULTS: Participants comprised 40 PET-positive subjects and 76 PET-negative subjects. Among the patient background characteristics, mean age was slightly but significantly higher in the PETpositive group (66 years) than in the PET-negative group (64 years; p¼0.0485). No significant differences were seen in PSA level, clinical T stage or Gleason Score (GS). Operative time, console time and volume of blood loss also showed no differences between groups, and no patients in either group suffered rectal perforation or required blood transfusion. Postoperative urethral balloon retention time and urinary continence rate at 3 months postoperatively were comparable between groups. Postoperative pathological results showed significantly higher values for the following parameters in the PET-positive group than in the PET-negative group: extraprostatic invasion (45.0% vs 22.4%; p¼0.0185); positive margin (30.0% vs 13.2%; p¼0.0445); and GS ¼8 (52.5% vs 23.7%; p¼0.00343). Multivariate analysis also showed that PET positivity tended to be associated with positive margins (odds ratio (OR), 2.45; p¼0.0819) and extraprostatic invasion (OR, 2.34; p¼0.0529), while GS ¼8 was a significant predictor (OR, 3.08; p¼0.0208).
CONCLUSIONS: In RALP, FDG uptake should be considered a predictor of high-grade disease and a risk factor for positive margins. 
Source of

INTRODUCTION AND OBJECTIVES:
Retzius-sparing (posterior or 0 Bocciardi 0 approach) of robot-assisted radical prostatectomy (RARP) has been recently suggested as a feasible alternative to the standard (anterior or 0 Menon 0 approach) RARP. We compared urinary continence (UC), sexual function (SF), oncological outcomes, and postoperative complications over a short term (~1-year) follow up for patients undergoing posterior vs. anterior approach RARP in a randomized trial.
METHODS: 120 patients with low-intermediate risk prostate cancer (PCa) undergoing RARP by a single surgeon were randomized to posterior (n¼60) or anterior RARP (n¼60). Recovery of SF was defined as a) erections sufficient for penetrative intercourse (ESI), and b) Sexual Health Inventory for Men (SHIM) score 17. UC recovery was defined as use of 0 pad/one security pad per day. Both UC and SF recovery data were collected by an independent third party (MUSIC registry) using validated patient-reported questionnaires. Oncologic outcomes consisted of positive surgical margins (PSM) and short term (~1 year) biochemical recurrence-free survival (BCRFS).
RESULTS: There were no significant differences in UC at 6-or 12-months post-RARP (98.4% in posterior vs. 95% in anterior RARP) or urinary function scores in the two arms (figure 1). Amongst preoperatively potent men (SHIM 17), 72.4% in anterior and 83.7% in posterior RARP group were able to have ESI one year after surgery (p¼0.6); 46.2% and 59.2% had regained SHIM 17 by the same time point (figure 2). There were no significant differences in the incidence of PSM (25% in posterior vs. 13.3% in anterior RARP), BCRFS (91.5% vs. 94.4% respectively) or postoperative complications over a median follow-up of 13.5 months.
CONCLUSIONS: In this randomized trial of patients with lowintermediate risk PCa, UC, SF, postoperative complications, and BCR rates were comparable at 12 months in patients undergoing 0 Bocciardi 0 vs. 0 Menon 0 approach RARP. 197, No. 4S, Supplement, Tuesday, May 16, 2017 exerted by the pneumoperitoneum. The aim of this study is to compare outcomes of RARP with preventive ligation versus delayed ligation of the DVC in a phase III randomized controlled trial. METHODS: After IRB approval, a prospective randomized controlled trail is recruiting patients submitted to RARP at our institution since February 2015. Exclusion criteria are: congenital or acquired coagulation disorders and salvage radical prostatectomy. After obtaining an informed consent, patients are randomized into treatment arms on a 1:1 ratio. RARP is performed according to the Patel technique, by 2 experienced robotic surgeons, with PL (1-0 Monocrylâ CT-1, after the opening of endopelvic fascia and before bladder neck dissection) or DL (3-0 Monocrylâ UR-6, once the prostatectomy is completed). Patients 0 characteristics and data are recorded in a prospective maintained database. The primary endpoint is estimated blood loss (EBL) during prostatectomy (considering significant a difference of 30 ml or higher). Secondary endpoints are: transfusion rate, positive surgical margins (PSMs) in general and apical PSMs in particular and 1-month PSA and continence (defined as the use of 0 pad or 1 security pad per day). Pearson 0 s chi-square test was applied to all variables, with a chi-square probability of 0.05 or less considered statistically significant. RESULTS: Overall, 154 patients were randomized from February 2015 to August 2016 (86 patients with PL and 68 with DL). The two groups had comparable preoperative features and no statistically significant differences were found in term of primary and secondary endpoints with the exception of the rate of apical PSMs, higher in the PL group (table 1) .
CONCLUSIONS: A DL of the DVC is associated to a greater blood loss, even without any clinical significance, and seems to be protective on the risk of apical PSMs, with no detrimental effects on perioperative course and functional outcomes.
Source of Funding: None
MP97-06 INGUINAL HERNIA AFTER RADICAL PROSTATECTOMY: INCIDENCE AND RISKS FACTORS.
Giacomo Perugia*, Pier Paolo Prontera, Emanuele Corongiu, Giuseppe Borgoni, Milena Polese, Antonio Rossi, Piergiorgio Tuzzolo, Marcello Liberti, Rome, Italy INTRODUCTION AND OBJECTIVES: The number of patients (pts.) undergoing radical prostatectomy has increased due to early detection of prostate cancer. The two most frequently occurring and well descrbed complications of radical prostatectomy are incontinence and impotence. Inguinal hernia (IH) has emerged as an additional complication with an estimated incidence of 15-20% after radical retropubic prostatectomy (RRP), 7,4% after laparoscopic prostatectomy and 5,8% after robotic prostatectomy. The internal inguinal ring is composed of transversalis fascia and suspended by the transversus abdomen muscle, so that injury to these structures or their nerve supply during surgery could be associated with the development of an indirect IH. The objective of the study is to assess the incidence and the risk factors for an IH development in a series of pts. undergone RRP.
METHODS: 360 pts. age ranged from 51 to 73 years, underwent RRP by a single surgeon. During the follow up many pts. complained the development of an IH not detected before surgery. This finding stimulated the Authors to screen all pts. for a post surgical IH by means of physical examination, upstanding ultrasonography and a questionnaire designed to capture the development of clinical IH. 86 pts. responded or were evaluable for the study. The potential risk factors for IH like a previous hernia, increasing age, BMI, bladder neck contracture,intraoperative profuse bleeding > 1000 ml., diabetes or infection of the surgical wound, were evaluated. RESULTS: 15 pts. (17,4%) developed a postoperative IH from 6 months to two years after RRP. 27 pts.(31,4%) underwent IH repair before RRP and of these,7 pts.(8,1%)developed a contralateral postoperative IH. Important risk factors for the development of post-RRP IH were a low BMI <25KG/m2 (40%)and diabetes (27%)in pts. with increasing age (mean 64,2 yrs.) while the other risk factors considered were not significantly associated with the postoperative IH risk.
CONCLUSIONS: A higher incidence of IH is noted in the post radical prostatectomy population compared with the general adult male population, suggesting that the procedure has an increased risk of IH formation. The incision of the transversalis fascia, a component of the internal inguinal ring, is the surgical step that rise the risk for an hernia formation. Old pts. with a low BMI and diabetes are particularly prone to increased morbidity from IH. Urologists should consider this finding when counseling pts. for complications, and a prophylactic surgery for high risk subjects should be considered at the time of radical prostatectomy to decrease the risk of postoperative IH formation.
INTRODUCTION AND OBJECTIVES:
The aim of this study was to evaluate the impact of the year of surgery on clinical, pathological and oncological outcomes in N+ prostate cancer (PCa) patients who underwent radical prostatectomy (RP) and extended pelvic lymph node dissection (ePLND) METHODS: 1,653 patients with N+ PCa treated with RP and ePLND at two tertiary care referral centres between 1998 and 2013. Lowess functions were used for graphical representation of the year-byyear trends in clinical, pathological characteristics and use of adjuvant treatments. Linear regression was used to test statistical significance of those temporal trends. Multivariable Cox regression analyses (MVA) were used to assess the relationship between year of surgery and oncological outcomes, namely biochemical recurrence-BCR and clinical recurrence-CR. Covariates consisted of patient age, preoperative PSA, pathological stage (pT2 vs. pT3a vs. pT3b), positive surgical margins-PSM, pathological Gleason score (6 vs. 3+4 vs. 4+3 vs. 8) and year of surgery RESULTS: Overall, 50.6 and 20.1% had BCR and CR, respectively. A significant decrease in the median PSA was observed over time (p¼0.02). A similar trend was seen for clinical stage T3 (from 24.8% in 1998 to 6.7% in 2013; p<0.001). Conversely, biopsy Gleason 8 dramatically increased from 23% in 1998 to 53.1% in 2013 (p<0.001). We observed a considerable increase in the median number of lymph nodes
